Full Text View
Tabular View
Study Results
Related Studies
Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation
This study has been completed.
Study NCT00287053   Information provided by Pennington Biomedical Research Center
First Received: February 2, 2006   Last Updated: April 21, 2009   History of Changes
Study Type: Interventional
Study Design: Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment
Condition: Healthy
Intervention: Drug: divalproex sodium

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
1 Divalproex Sodium
2 Placebo

Participant Flow:   Overall Study
  1 2
STARTED   30     27  
COMPLETED   26     26  
NOT COMPLETED   4     1  



  Baseline Characteristics
  Hide Baseline Characteristics

Reporting Groups
  Description
1 Divalproex Sodium
2 Placebo

Baseline Measures
  1 2 Total
Number of Participants  
[units: participants]
30 27 57
Age  
[units: participants]
     
<=18 years 0 0 0
Between 18 and 65 years 30 27 57
>=65 years 0 0 0
Age  
[units: years]
Mean ± Standard Deviation
28.2 ± 8.6 32 ± 10.2 30.3 ± 9.5
Gender  
[units: participants]
     
Female 18 15 33
Male 12 12 24
Region of Enrollment  
[units: participants]
     
United States 30 27 57



  Outcome Measures

1.  Primary:   Change in Food Intake.   [ February 2006 to September 2006 ]


  Serious Adverse Events
  Hide Serious Adverse Events
No Serious Adverse Events Entered.


  Other Adverse Events
  Show Other Adverse Events


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Limitations and Caveats
Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.  


Results Point of Contact:  
Name/Title: Corby Martin, Ph.D.; Assistant Professor
Organization: Pennington Biomedical Reseach Center
phone: 225-763-2585
e-mail: martinck@pbrc.edu


No publications provided by Pennington Biomedical Research Center

Publications automatically indexed to this study:

Responsible Party: Pennington Biomedical Research Center ( Corby Martin )
Study ID Numbers: 25031
Study First Received: February 2, 2006
Results First Received: April 21, 2009
Last Updated: April 21, 2009
ClinicalTrials.gov Identifier: NCT00287053     History of Changes
Health Authority: United States: Institutional Review Board